Medical Director, Comprehensive Stroke Center
333 W. 10th Ave
Columbus OH 43210
Phone: (614) 293-4969
Vivien.Lee@osumc.edu
Current Research: Dr. Lee's clinical research interests include thrombolysis related complications in acute ischemic stroke and predictors of outcome after subarachnoid hemorrhage.
Education:
Degree: MD, Pennsylvania State University College of Medicine
Postdoctoral Training: Cleveland Clinic Foundation and Mayo Clinic College of Medicine
Honors/News:
2016 American Academy of Neurology Fellow
Grants and Funding:
1. Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
PI: Boehringer Ingelheim Study team
Funding Source: Boehringer Ingelheim
Annual Amount:
Role: Site PI
Dates: 7/2016-current
2. Prospective Study on Intravenous Thrombolysis Related Coagulopathy in Acute Ischemic Stroke
PI: Vivien Lee, MD
Funding Source: Neurological Sciences Department Research Grant
Annual amount: $20,000
Role: PI
Dates 11/2015-11/2016
3. Insulin Resistance Intervention after Stroke (IRIS) trial
PI: Walter Kernan, MD
Funding source: NINDS (NS044876-03)
Annual amount: $64,194
Role: Local site Principal Investigator
Dates: 7/2011 – 6/2016
4. Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS 4)
PI: DIAS 4 Study team
Funding source: H. Lundbeck A/S (NCT00856661)
Annual amount: $10,000
Role: Local site Principal Investigator
Dates: 6/2012 – 2014
5. GORE HELEX Septal Occluder for Patent Foramen Ovale (PFO) Closure in Stroke Patients- The Gore REDUCE Clinical Study (HLX 06-03)
PI: Scott E. Kasner, MD, FAHA
Funding source: W.L.Gore & Associates (NCT00738894)
Annual amount: $3000
Role: Local site co- Principal Investigator
Dates: 9/2008 – 6/2016
RESPECT ESUS trial